Wells Fargo’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.3M Buy
41,687
+1,878
+5% +$104K ﹤0.01% 2826
2025
Q1
$1.93M Buy
39,809
+1,013
+3% +$49K ﹤0.01% 2836
2024
Q4
$1.5M Buy
38,796
+9,423
+32% +$364K ﹤0.01% 3000
2024
Q3
$1.32M Sell
29,373
-817
-3% -$36.8K ﹤0.01% 3037
2024
Q2
$1.05M Buy
30,190
+397
+1% +$13.8K ﹤0.01% 3150
2024
Q1
$862K Buy
29,793
+13,636
+84% +$394K ﹤0.01% 3228
2023
Q4
$370K Sell
16,157
-60,407
-79% -$1.39M ﹤0.01% 3705
2023
Q3
$1.28M Buy
76,564
+5,513
+8% +$92K ﹤0.01% 2916
2023
Q2
$1.96M Buy
71,051
+37,087
+109% +$1.02M ﹤0.01% 2782
2023
Q1
$781K Buy
33,964
+33,927
+91,695% +$780K ﹤0.01% 3325
2022
Q4
$404 Sell
37
-2,307
-98% -$25.2K ﹤0.01% 6112
2022
Q3
$19K Sell
2,344
-3,281
-58% -$26.6K ﹤0.01% 5103
2022
Q2
$44K Sell
5,625
-20,394
-78% -$160K ﹤0.01% 4813
2022
Q1
$616K Sell
26,019
-14,339
-36% -$339K ﹤0.01% 4003
2021
Q4
$1.38M Sell
40,358
-18,371
-31% -$628K ﹤0.01% 3595
2021
Q3
$1.04M Buy
58,729
+28,711
+96% +$509K ﹤0.01% 3976
2021
Q2
$1.35M Sell
30,018
-8,417
-22% -$377K ﹤0.01% 3798
2021
Q1
$995K Sell
38,435
-35,096
-48% -$909K ﹤0.01% 3991
2020
Q4
$1.48M Buy
73,531
+47,287
+180% +$954K ﹤0.01% 3667
2020
Q3
$514K Buy
26,244
+11,275
+75% +$221K ﹤0.01% 4207
2020
Q2
$265K Sell
14,969
-33,576
-69% -$594K ﹤0.01% 4592
2020
Q1
$343K Buy
48,545
+15,067
+45% +$106K ﹤0.01% 4185
2019
Q4
$237K Buy
33,478
+7,504
+29% +$53.1K ﹤0.01% 4701
2019
Q3
$312K Buy
25,974
+5,421
+26% +$65.1K ﹤0.01% 4552
2019
Q2
$248K Buy
20,553
+4,224
+26% +$51K ﹤0.01% 4684
2019
Q1
$205K Sell
16,329
-2,016
-11% -$25.3K ﹤0.01% 4741
2018
Q4
$123K Buy
18,345
+5,744
+46% +$38.5K ﹤0.01% 4970
2018
Q3
$130K Sell
12,601
-604
-5% -$6.23K ﹤0.01% 5016
2018
Q2
$89K Buy
13,205
+4,660
+55% +$31.4K ﹤0.01% 5184
2018
Q1
$73K Buy
8,545
+3,045
+55% +$26K ﹤0.01% 5174
2017
Q4
$115K Sell
5,500
-4,065
-42% -$85K ﹤0.01% 5034
2017
Q3
$169K Buy
9,565
+3,617
+61% +$63.9K ﹤0.01% 4819
2017
Q2
$67K Buy
5,948
+729
+14% +$8.21K ﹤0.01% 5067
2017
Q1
$67K Hold
5,219
﹤0.01% 5084
2016
Q4
$115K Buy
+5,219
New +$115K ﹤0.01% 4863